Loading...
XJPX7600
Market cap103mUSD
Jan 17, Last price  
616.00JPY
1D
-2.22%
1Q
-10.20%
Jan 2017
-25.51%
Name

Japan Medical Dynamic Marketing Inc

Chart & Performance

D1W1MN
XJPX:7600 chart
P/E
12.76
P/S
0.70
EPS
48.29
Div Yield, %
2.12%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
6.74%
Revenues
23.18b
+8.78%
11,447,224,00010,394,695,0009,894,445,0009,531,250,00008,134,461,0009,459,467,00011,855,226,00013,024,747,00013,629,522,00014,807,726,00016,728,891,00018,083,187,00016,738,174,00019,193,098,00021,307,946,00023,177,747,000
Net income
1.27b
-10.68%
286,749,000-226,702,000-2,358,375,00071,132,0000-397,894,000286,656,000-391,528,000800,546,0001,130,703,0001,425,466,0001,984,583,0002,164,945,0001,664,517,0002,135,693,0001,423,719,0001,271,683,000
CFO
2.10b
-3.72%
4,162,375,0002,882,433,0003,286,391,0001,742,797,0001,647,659,000-457,187,0001,967,953,0001,566,887,0002,038,193,0002,562,533,0002,367,421,0002,731,181,0002,599,761,0003,111,665,0002,186,226,0002,104,913,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
URL
https://www.jmdm.co.jp/
IPO date
Mar 24, 2000
Employees
488
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
23,177,747
8.78%
21,307,946
11.02%
19,193,098
14.67%
Cost of revenue
13,715,727
11,963,977
9,827,533
Unusual Expense (Income)
NOPBT
9,462,020
9,343,969
9,365,565
NOPBT Margin
40.82%
43.85%
48.80%
Operating Taxes
331,297
334,070
608,096
Tax Rate
3.50%
3.58%
6.49%
NOPAT
9,130,723
9,009,899
8,757,469
Net income
1,271,683
-10.68%
1,423,719
-33.34%
2,135,693
28.31%
Dividends
(343,969)
(317,287)
(290,201)
Dividend yield
1.78%
1.16%
0.67%
Proceeds from repurchase of equity
(72,934)
377,110
(401)
BB yield
0.38%
-1.37%
0.00%
Debt
Debt current
1,199,600
1,081,286
590,209
Long-term debt
366,678
883,127
1,302,575
Deferred revenue
1,341,518
Other long-term liabilities
1,557,095
8,005
1,149,074
Net debt
(912,928)
(1,112,195)
(872,952)
Cash flow
Cash from operating activities
2,104,913
2,186,226
3,111,665
CAPEX
(1,802,462)
(1,315,553)
(1,585,010)
Cash from investing activities
(1,804,728)
(1,481,919)
(1,750,123)
Cash from financing activities
(840,710)
(514,780)
(1,287,745)
FCF
6,556,207
7,559,902
7,330,835
Balance
Cash
2,321,552
2,804,928
2,590,849
Long term investments
157,654
271,680
174,887
Excess cash
1,320,319
2,011,211
1,806,081
Stockholders' equity
19,678,371
20,907,795
19,016,031
Invested Capital
27,334,630
24,162,858
22,416,420
ROIC
35.46%
38.69%
40.38%
ROCE
33.02%
35.19%
37.81%
EV
Common stock shares outstanding
26,322
26,352
26,384
Price
735.00
-29.39%
1,041.00
-36.45%
1,638.00
-27.68%
Market cap
19,346,958
-29.47%
27,432,223
-36.52%
43,216,589
-27.68%
EV
18,526,510
26,450,490
42,448,315
EBITDA
11,057,205
10,893,781
10,786,342
EV/EBITDA
1.68
2.43
3.94
Interest
31,778
18,145
29,700
Interest/NOPBT
0.34%
0.19%
0.32%